Paradigm Biocapital Advisors LP: 13F holdings
CIK 18556552026Q2
| Positions | 28 |
|---|
| Reported value | $5.3bn |
|---|
| Filed | 2026-08-14 |
|---|
Change since last quarter
| Positions | 28 (-7 vs prior quarter) |
|---|
| Reported value | $5.3bn (+9.1%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| RVMD REVOLUTION MEDICINES INC | 6,361,323 | $1.2bn | 22.3% |
| NUVL NUVALENT INC | 5,924,433 | $731.7m | 13.7% |
| EWTX EDGEWISE THERAPEUTICS INC | 10,215,455 | $415.1m | 7.8% |
| GMAB GENMAB A/S | 13,133,131 | $360.8m | 6.8% |
| SYRE SPYRE THERAPEUTICS INC | 3,840,778 | $341.0m | 6.4% |
| APOGEE THERAPEUTICS INC | 1,576,385 | $209.2m | 3.9% |
| ORKA ORUKA THERAPEUTICS INC | 2,144,526 | $204.1m | 3.8% |
| TNGX TANGO THERAPEUTICS INC | 6,357,523 | $198.7m | 3.7% |
| BLTE BELITE BIO INC | 1,232,877 | $189.8m | 3.6% |
| ERAS ERASCA INC | 9,550,000 | $175.0m | 3.3% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1855655")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples